TDP-43 pathology is frequently detected in pathologically confirmed AD brains in up to 57% of AD cases [10, 115–123], where it has been associated with worse brain atrophy and greater memory loss in AD patients [116]. Here, TARDBP is linked to Alzheimer disease.